investorscraft@gmail.com

Intrinsic ValueKo Yo Chemical (Group) Limited (0827.HK)

Previous CloseHK$0.03
Intrinsic Value
Upside potential
Previous Close
HK$0.03

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ko Yo Chemical operates as a diversified chemical producer focused primarily on China's agricultural and industrial sectors. The company generates revenue through manufacturing and distributing chemical fertilizers including bulk blended fertilizer, urea, soda ash, and ammonia chloride, while also providing comprehensive agrotechnical services to farmers under its Jiu Yuan Ce Fang brand. Its operations extend to upstream activities with phosphorous mine exploration and downstream chemical production technology development, including engineering plastics manufacturing. The company maintains a vertically integrated approach that spans from raw material extraction to finished product distribution, positioning itself within China's competitive basic materials sector. While serving essential agricultural and industrial markets, the company faces intense competition from larger state-owned enterprises and international chemical producers operating in the region.

Revenue Profitability And Efficiency

The company reported HKD 2.60 billion in revenue for the period but experienced significant challenges with a net loss of HKD 505.4 million and negative diluted EPS of HKD 0.0838. Operating cash flow was negative HKD 103.3 million, indicating substantial operational strain. The absence of capital expenditures suggests either deferred investments or limited capacity for growth initiatives during this challenging period.

Earnings Power And Capital Efficiency

Current financial performance reflects severe pressure on earnings power, with negative profitability metrics across all major indicators. The negative operating cash flow combined with substantial net losses indicates inefficient capital deployment and operational challenges. The company's ability to generate returns on invested capital appears significantly constrained by current market conditions and operational inefficiencies.

Balance Sheet And Financial Health

The balance sheet shows concerning financial health with HKD 8.1 million in cash against HKD 3.40 billion in total debt, creating a highly leveraged position. This substantial debt burden relative to limited liquidity raises significant solvency concerns. The negative cash flow further exacerbates the company's ability to service its debt obligations and maintain normal operations.

Growth Trends And Dividend Policy

Current trends indicate contraction rather than growth, with negative profitability and cash generation. The company maintained a zero dividend policy, consistent with its loss-making position and cash constraints. The absence of capital expenditures suggests limited investment in future growth capabilities, potentially impacting long-term competitive positioning in the chemical and fertilizer markets.

Valuation And Market Expectations

With a market capitalization of HKD 180.8 million, the company trades at a significant discount to its revenue base, reflecting market skepticism about recovery prospects. The low beta of 0.142 suggests the stock exhibits lower volatility than the broader market, possibly indicating limited investor interest or perception of fundamental challenges outweighing market cyclicality.

Strategic Advantages And Outlook

The company's vertically integrated model provides some cost control advantages, though current financial distress overshadows these benefits. Outlook remains challenging given high leverage, negative cash flow, and competitive market pressures. Recovery would require significant operational improvements, debt restructuring, or favorable market conditions in China's chemical and agricultural sectors.

Sources

Company financial statementsHong Kong Stock Exchange filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount